Financhill
Sell
22

ICCT Quote, Financials, Valuation and Earnings

Last price:
$0.0000
Seasonality move :
--
Day range:
$0.0010 - $0.0040
52-week range:
$0.0001 - $0.2200
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
13.1K
Avg. volume:
6.2K
1-year change:
--
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ICCT
iCoreConnect, Inc.
-- -- -- -- --
CTTH
CTT Pharmaceutical Holdings, Inc.
-- -- -- -- --
MAHN
Mid-Atlantic Home Health Network, Inc.
-- -- -- -- --
RNBI
Rainbow International Corp.
-- -- -- -- --
SNYR
Synergy CHC
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ICCT
iCoreConnect, Inc.
$0.0010 -- -- -- $0.00 0% --
CTTH
CTT Pharmaceutical Holdings, Inc.
$0.0510 -- $2.9M -- $0.00 0% --
MAHN
Mid-Atlantic Home Health Network, Inc.
$0.1100 -- $1.2K -- $0.00 0% --
RNBI
Rainbow International Corp.
$0.0000 -- $300 -- $0.00 0% --
SNYR
Synergy CHC
-- -- -- -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ICCT
iCoreConnect, Inc.
-- 0.000 -- --
CTTH
CTT Pharmaceutical Holdings, Inc.
17.49% 3.053 0.89% 1.62x
MAHN
Mid-Atlantic Home Health Network, Inc.
-- 19,740.125 -- 0.00x
RNBI
Rainbow International Corp.
-- 311.936 -- --
SNYR
Synergy CHC
-- 0.000 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ICCT
iCoreConnect, Inc.
-- -- -- -- -- --
CTTH
CTT Pharmaceutical Holdings, Inc.
-$1.6K -$7.3K -416.43% -668.98% -- -$16.4K
MAHN
Mid-Atlantic Home Health Network, Inc.
-- -$14.8K -1.15% -3.38% -- --
RNBI
Rainbow International Corp.
-- -- -- -- -- --
SNYR
Synergy CHC
-- -- -- -- -- --

iCoreConnect, Inc. vs. Competitors

  • Which has Higher Returns ICCT or CTTH?

    CTT Pharmaceutical Holdings, Inc. has a net margin of -- compared to iCoreConnect, Inc.'s net margin of --. iCoreConnect, Inc.'s return on equity of -- beat CTT Pharmaceutical Holdings, Inc.'s return on equity of -668.98%.

    Company Gross Margin Earnings Per Share Invested Capital
    ICCT
    iCoreConnect, Inc.
    -- -- --
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    -- -- $99.5K
  • What do Analysts Say About ICCT or CTTH?

    iCoreConnect, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand CTT Pharmaceutical Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that iCoreConnect, Inc. has higher upside potential than CTT Pharmaceutical Holdings, Inc., analysts believe iCoreConnect, Inc. is more attractive than CTT Pharmaceutical Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    ICCT
    iCoreConnect, Inc.
    0 0 0
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    0 0 0
  • Is ICCT or CTTH More Risky?

    iCoreConnect, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CTT Pharmaceutical Holdings, Inc. has a beta of 0.371, suggesting its less volatile than the S&P 500 by 62.851%.

  • Which is a Better Dividend Stock ICCT or CTTH?

    iCoreConnect, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CTT Pharmaceutical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iCoreConnect, Inc. pays -- of its earnings as a dividend. CTT Pharmaceutical Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ICCT or CTTH?

    iCoreConnect, Inc. quarterly revenues are --, which are smaller than CTT Pharmaceutical Holdings, Inc. quarterly revenues of --. iCoreConnect, Inc.'s net income of -- is lower than CTT Pharmaceutical Holdings, Inc.'s net income of -$7.3K. Notably, iCoreConnect, Inc.'s price-to-earnings ratio is -- while CTT Pharmaceutical Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iCoreConnect, Inc. is -- versus -- for CTT Pharmaceutical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ICCT
    iCoreConnect, Inc.
    -- -- -- --
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    -- -- -- -$7.3K
  • Which has Higher Returns ICCT or MAHN?

    Mid-Atlantic Home Health Network, Inc. has a net margin of -- compared to iCoreConnect, Inc.'s net margin of --. iCoreConnect, Inc.'s return on equity of -- beat Mid-Atlantic Home Health Network, Inc.'s return on equity of -3.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    ICCT
    iCoreConnect, Inc.
    -- -- --
    MAHN
    Mid-Atlantic Home Health Network, Inc.
    -- -- -$16.4K
  • What do Analysts Say About ICCT or MAHN?

    iCoreConnect, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Mid-Atlantic Home Health Network, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that iCoreConnect, Inc. has higher upside potential than Mid-Atlantic Home Health Network, Inc., analysts believe iCoreConnect, Inc. is more attractive than Mid-Atlantic Home Health Network, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    ICCT
    iCoreConnect, Inc.
    0 0 0
    MAHN
    Mid-Atlantic Home Health Network, Inc.
    0 0 0
  • Is ICCT or MAHN More Risky?

    iCoreConnect, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Mid-Atlantic Home Health Network, Inc. has a beta of 2,095.285, suggesting its more volatile than the S&P 500 by 209428.493%.

  • Which is a Better Dividend Stock ICCT or MAHN?

    iCoreConnect, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mid-Atlantic Home Health Network, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iCoreConnect, Inc. pays -- of its earnings as a dividend. Mid-Atlantic Home Health Network, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ICCT or MAHN?

    iCoreConnect, Inc. quarterly revenues are --, which are smaller than Mid-Atlantic Home Health Network, Inc. quarterly revenues of --. iCoreConnect, Inc.'s net income of -- is lower than Mid-Atlantic Home Health Network, Inc.'s net income of -$14.8K. Notably, iCoreConnect, Inc.'s price-to-earnings ratio is -- while Mid-Atlantic Home Health Network, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iCoreConnect, Inc. is -- versus -- for Mid-Atlantic Home Health Network, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ICCT
    iCoreConnect, Inc.
    -- -- -- --
    MAHN
    Mid-Atlantic Home Health Network, Inc.
    -- -- -- -$14.8K
  • Which has Higher Returns ICCT or RNBI?

    Rainbow International Corp. has a net margin of -- compared to iCoreConnect, Inc.'s net margin of --. iCoreConnect, Inc.'s return on equity of -- beat Rainbow International Corp.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ICCT
    iCoreConnect, Inc.
    -- -- --
    RNBI
    Rainbow International Corp.
    -- -- --
  • What do Analysts Say About ICCT or RNBI?

    iCoreConnect, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Rainbow International Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that iCoreConnect, Inc. has higher upside potential than Rainbow International Corp., analysts believe iCoreConnect, Inc. is more attractive than Rainbow International Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    ICCT
    iCoreConnect, Inc.
    0 0 0
    RNBI
    Rainbow International Corp.
    0 0 0
  • Is ICCT or RNBI More Risky?

    iCoreConnect, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Rainbow International Corp. has a beta of -63.421, suggesting its less volatile than the S&P 500 by 6442.142%.

  • Which is a Better Dividend Stock ICCT or RNBI?

    iCoreConnect, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Rainbow International Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iCoreConnect, Inc. pays -- of its earnings as a dividend. Rainbow International Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ICCT or RNBI?

    iCoreConnect, Inc. quarterly revenues are --, which are smaller than Rainbow International Corp. quarterly revenues of --. iCoreConnect, Inc.'s net income of -- is lower than Rainbow International Corp.'s net income of --. Notably, iCoreConnect, Inc.'s price-to-earnings ratio is -- while Rainbow International Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iCoreConnect, Inc. is -- versus -- for Rainbow International Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ICCT
    iCoreConnect, Inc.
    -- -- -- --
    RNBI
    Rainbow International Corp.
    -- -- -- --
  • Which has Higher Returns ICCT or SNYR?

    Synergy CHC has a net margin of -- compared to iCoreConnect, Inc.'s net margin of --. iCoreConnect, Inc.'s return on equity of -- beat Synergy CHC's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ICCT
    iCoreConnect, Inc.
    -- -- --
    SNYR
    Synergy CHC
    -- -- --
  • What do Analysts Say About ICCT or SNYR?

    iCoreConnect, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Synergy CHC has an analysts' consensus of -- which suggests that it could fall by --. Given that iCoreConnect, Inc. has higher upside potential than Synergy CHC, analysts believe iCoreConnect, Inc. is more attractive than Synergy CHC.

    Company Buy Ratings Hold Ratings Sell Ratings
    ICCT
    iCoreConnect, Inc.
    0 0 0
    SNYR
    Synergy CHC
    0 0 0
  • Is ICCT or SNYR More Risky?

    iCoreConnect, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Synergy CHC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock ICCT or SNYR?

    iCoreConnect, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Synergy CHC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iCoreConnect, Inc. pays -- of its earnings as a dividend. Synergy CHC pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ICCT or SNYR?

    iCoreConnect, Inc. quarterly revenues are --, which are smaller than Synergy CHC quarterly revenues of --. iCoreConnect, Inc.'s net income of -- is lower than Synergy CHC's net income of --. Notably, iCoreConnect, Inc.'s price-to-earnings ratio is -- while Synergy CHC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iCoreConnect, Inc. is -- versus -- for Synergy CHC. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ICCT
    iCoreConnect, Inc.
    -- -- -- --
    SNYR
    Synergy CHC
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 20

Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.

Buy
54
BMRN alert for Dec 20

BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.

Buy
82
RKLB alert for Dec 20

Rocket Lab Corp. [RKLB] is up 17.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock